Menu
1 min read · estimated
APPROVED USE
What FDA approved
The FDA removed the fasting requirement for selumetinib capsules in the then-labeled population: children aged 2 years and older with NF1 and symptomatic, inoperable plexiform neurofibromas.
LAMPGEN ANALYSIS
Why it matters
More flexible administration can help families fit twice-daily treatment into meals and school schedules.
What research teams should watch
Update medication counseling and study drug administration instructions; maintain the required eye and cardiac follow-up.
PRIMARY RECORDS